dr. smith on frontline treatment options in mcl
Published 4 years ago • 90 plays • Length 1:41Download video MP4
Download video MP3
Similar videos
-
0:55
dr. smith on safety profiles of btk inhibitors in mcl
-
1:51
dr. smith on frontline treatment considerations in cll
-
1:20
dr. martin on the frontline treatment landscape of mcl
-
1:22
dr. leslie on frontline treatment options in follicular lymphoma
-
1:48
dr. leslie on the current frontline treatment landscape in mcl
-
1:07
dr. kahl discusses the potential of frontline ibrutinib in mcl
-
6:00
mantle cell lymphoma: improved prognosis
-
42:29
mantle cell lymphoma (case studies)
-
10:42
understanding mantle cell lymphoma with jia ruan, md, ph.d.
-
4:54
options for upfront therapy in mcl
-
1:02
dr. goy on the progression of mcl treatment
-
1:28
dr. goy on the evolution of treatment selection in mcl
-
1:23
dr. rule on the future treatment paradigm in mcl
-
1:43
the role of targeted therapies in the frontline treatment of mantle cell lymphoma
-
1:13
dr. leslie on remaining questions address in mcl
-
1:22
dr. ruan on unanswered questions regarding treatment decisions in mcl
-
0:55
dr. wang on the evolution of treatment in mcl
-
1:43
dr. smith on emerging therapies in indolent lymphoma
-
3:42
mantle cell lymphoma: an overview on frontline therapy
-
0:58
dr. leslie on the benefits with zanubrutinib in mcl
-
1:09
dr. cohen on the potential of btk inhibitors in frontline treatment of mcl
-
1:05
dr. smith on using venetoclax versus ibrutinib in cll